An exciting new trial for #WNW - COBRRA compared apixaban vs rivaroxaban for VTE treatment and found a significantly decreased risk of bleeding associated with apixaban use (3.3% vs 7.1%); this RCT backs up the trend seen in retrospective data!
https://t.co/vJlquRGdIV
Not noninferior = INFERIOR
Take your blood thinners folks - still the gold standard for stroke prevention in patients with AF who don’t have clear contraindication to anticoagulation.
A messege from Dr Bassam Atallah:
"On #WorldPharmacistsDay, we recognize the crucial role pharmacists play in advancing safe, effective, and evidence-based cardiac care.
Thank you for your dedication to patients’ health."
#EmiratesCardiacSociety#ECS@batallah08
ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools & techniques to recognize HoFH & HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ https://t.co/bPzupFYxpz
#ACCEd#CholesterolEducationMonth
ICYMI: A new ACC/AHA Scientific Statement introduces the PREVENT risk calculator & details the supporting evidence & rationale behind its use.
Learn more: https://t.co/bZe8izHiZB #hypertension@JACCJournals
New in JACC HF:
#Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in #HFpEF
https://t.co/6q5JJWlrHq
Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF.
https://t.co/7ivf3aYVZ7
AFIRE RCT: Rivaroxaban monotherapy yielded a consistent net clinical benefit across all age groups, especially in older patients with atrial fibrillation and stable coronary artery disease. https://t.co/0uhqutYDvn
In frail, elderly #AFib patients previously on a vitamin K antagonist, switching to standard-dose direct-acting oral anticoagulant reduced stroke, fatal/intracranial bleeding, and death, despite more GI bleeding. https://t.co/VueCCDedLL #JACC#DOAC
Kudos to @mfiuzat, @batallah08, Robert Page & Orly Vardeny for shedding light on the training, practice, & roles of HF pharmacists. https://t.co/7U9mOuzUVQ
Congratulations to ACCP member Bassam Atallah and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: https://t.co/ytGNjUPHHt
@JACCPJournal#OpenAccess#MakingAnImpact#ACCP
Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist‐led protocol - Alaryani - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library https://t.co/LjAhDmSA45